Literature DB >> 19268774

Secondary chronic venous disease progresses faster than primary.

Nicos Labropoulos1, Antonios P Gasparis, Dina Pefanis, Luis R Leon, Apostolos K Tassiopoulos.   

Abstract

PURPOSE: To compare the progression rate of primary with secondary chronic venous disease (CVD).
METHODS: Patients with a first episode of proximal deep vein thrombosis (DVT), diagnosed by duplex ultrasound (DU) were included in group A - secondary CVD (41 patients, 46 limbs). DU was performed at least once, 1 year after the diagnosis, and repeated at 5 years. Group B - primary CVD (41 patients, 50 limbs) included age- and sex-matched patients with primary CVD and duration of 5 to 10 years to be comparable with that of group A. They had no history of DVT and were referred for reflux evaluation. All their veins were free of postthrombotic signs upon DU examination. Group C (15 patients, 30 limbs) had no signs and symptoms of CVD and were examined at baseline and 5 years later. This group of patients was also matched for age and sex. Clinic examinations were performed at 3, 6, and 12 months and yearly thereafter. The CEAP system was used to grade disease severity. The proximal veins were divided in the CFV, FV, and POPV segments for analysis. Thrombosed veins were subsequently graded as complete, partial, and fully recanalized. Recurrent DVT cases were also recorded.
RESULTS: At 5-year follow-up, the prevalence of skin damage was significantly higher in group A (11/46 vs group B 3/50, P = .019 and vs group C 0/30, P < .01). The progression to skin damage in group A was faster as it changed from 4% (2/46) at 1 year (P = 0.014) compared with the two other groups. In group A, 22 limbs had reflux, three had obstruction, 19 had combine reflux and obstruction, and two were normal. In group B, superficial, deep, and perforator vein reflux were seen in 50, 4, and 15 limbs, respectively. In group C, five limbs in four patients developed superficial reflux in which only two had symptoms. The CEAP class in this group was C0N = 25, C1 = 3, and C2 = 2. In group A, skin damage was significantly higher in limbs with combined proximal and distal obstruction as well as in limbs with combined reflux and obstruction (P = .012 and P = 0.013, respectively). DVT was found in 108 segments (25 CFV, 40 FV, and in 43 POPV), 82 at the first episode and 26 as an ipsilateral recurrence. Ipsilateral and contralateral recurrences were seen in 21.9% and 9.8% of patients, respectively. Complete recanalization occurred in 43 segments, partial in 55, and none in 10. Reflux occurred in 85.5% and 60.5% of the partially and completely recanalized segments, respectively (P = .006).
CONCLUSIONS: The progression of CVD is more rapid in postthrombotic limbs when compared with those with primary CVD. The incidence of CVD in normal individuals is small and its progression is slow. Poor prognostic factors for progression to advanced CVD include the combination of reflux and obstruction, ipsilateral recurrent DVT, and multi-segmental involvement.

Entities:  

Mesh:

Year:  2009        PMID: 19268774     DOI: 10.1016/j.jvs.2008.10.014

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

Review 1.  [Evidence of compression therapy].

Authors:  W Konschake; E Valesky; H Stege; M Jünger
Journal:  Hautarzt       Date:  2017-08       Impact factor: 0.751

2.  [Chronic venous insufficiency].

Authors:  B-M Taute
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

3.  Diagnosis of stenosis within the popliteal-femoral venous segment upon clinical presentation with a venous ulcer and subsequent successful treatment with venoplasty.

Authors:  Emma Dabbs; Alina Sheikh; David Beckett; Mark S Whiteley
Journal:  SAGE Open Med Case Rep       Date:  2017-11-03

4.  Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis.

Authors:  Angelo A Bignamini; Jiří Matuška
Journal:  Adv Ther       Date:  2020-01-27       Impact factor: 3.845

Review 5.  How Does Chronic Venous Disease Progress from the First Symptoms to the Advanced Stages? A Review.

Authors:  Nicos Labropoulos
Journal:  Adv Ther       Date:  2019-02-13       Impact factor: 3.845

6.  Validity and Reliability of the Hungarian Version of Aberdeen Varicose Vein Questionnaire.

Authors:  Gabriella Kiss; Dorottya Szabó; Eva Tékus; Gábor Jancsó; Endre Arató; Alexandra Makai; Melinda Járomi; Tibor Mintál
Journal:  Int J Environ Res Public Health       Date:  2022-01-31       Impact factor: 3.390

7.  microRNA-301a-3p is a potential biomarker in venous ulcers vein and gets involved in endothelial cell dysfunction.

Authors:  Ying Wang; Jingchen Du; Yu Liu; Shuhui Yang; Qingshan Wang
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

8.  LivRelief varicose veins cream in the treatment of chronic venous insufficiency of the lower limbs: A 6-week single arm pilot study.

Authors:  Heather C Dwyer; David C Baranowski; Perry V Mayer; Simona Gabriele
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

9.  Initiation of reticular and spider veins, incompetent perforantes and varicose veins in the saphenous vein network of the rat.

Authors:  Bernadett Bettina Patai; Gabriella Dornyei; Anna-Maria Tokes; Judit Reka Hetthessy; Alexander Fees; Gyorgy L Nadasy
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

10.  Comparative analysis of endovenous laser ablation versus ultrasound-guided foam sclerotherapy for the treatment of venous leg ulcers.

Authors:  Benedikt Weber; Elias Marquart; Julia Deinsberger; Stanislava Tzaneva; Kornelia Böhler
Journal:  Dermatol Ther       Date:  2022-01-27       Impact factor: 3.858

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.